Silo Pharma, Inc.


$1.61 USD

$0.02 (1.26%)

Average Volume
Market Capitalization
P/E Ratio
Dividend Yield
Price Target
Year High
Year Low
Payout Ratio
Current Ratio

Industry, Sector & symbol

Stock Exchange Other OTC
CEO Mr. Eric Weisblum
Industry Biotechnology
Sector Healthcare
Current Symbol SILO
CUSIP 82711P102
CIK 0001514183
Phone 718 400 9031
Currency USD
Employees 3
Country US


Debt-to-Equity Ratio -0.08
Payout Ratio 0.00
Current Ratio 13.14
Quick Ratio 13.02
Cash Ratio 0.29

Sales & Book Value

Annual Sales $72102
Price / Sales 58.34
Cash Flow -1.03
Price / Cash Flow -1.31
Price / Book 0.67

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating Neutral
Rating Score(0-5) 3
Research Coverage 0 Analysts


EPS (Most Recent Fiscal Year) $-1.71
Trailing P/E Ratio -1.15
PEG Ratio -0.06
P/E Growth -0.06
Net Income $-3.91M
Net Margin -6030.44%
Pretax Margin -5883.80%
Return on Equity -48.89%
Return on Assets -48.38%

Financials Score

AltmanZ Score -0.31
Piotroski Score 2.00
Working Capital 8.24M
Total Assets 8.99M
Ebit -4.35M
Market Cap 4.21M
Total Liabilities 1.49M

Poll Results

About Silo Pharma, Inc. (PNK:SILO) Stock

Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University of Maryland, The Regents of the University of California, and Columbia University. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is headquartered in Englewood Cliffs, New Jersey. ...

Silo Pharma shares take off as anxiety and PTSD therapeutic candidate achieves milestone

2023-08-08 13:12:51

Silo Pharma shares rose on Tuesday after the development stage biopharmaceutical company announced it has advanced the formulation development of its therapeutic candidate SPC-15, achieving a liquid nasal formulation. This formulation of SPC-15, a targeted prophylactic treatment using ketamine compositions, is being investigated as a method of treatment and prevention of anxiety, post-traumatic stress disorder (PTSD) and other stress disorders.

Silo Pharma to Present at Psychedelic Drug Development Conference

2023-04-24 08:15:00

ENGLEWOOD CLIFFS, NJ, April 24, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc.  (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced that James Kuo, M.D., Vice President of R&D, will speak at the 3rd Annual Psychedelic Therapeutics and Drug Development Conference being held May 15-16, 2023, in person, at the Hilton San Francisco Airport Bayfront in Burlingame, CA.

7 Top Penny Stocks To Watch With Big News This Week

2023-01-31 09:30:53

Penny Stocks With News Light Up The Scanners This Week This week

3 Essential Strategies for Penny Stocks Trading in 2023

2022-12-31 11:00:00

Are you using these penny stocks trading strategies? The post 3 Essential Strategies for Penny Stocks Trading in 2023 appeared first on Penny Stocks to Buy, Picks, News and Information |

Best Penny Stocks To Buy Before 2023? 4 To Watch Now

2022-12-30 09:54:31

Penny stocks to watch this week with news before 2023. The post Best Penny Stocks To Buy Before 2023?

Frequently Asked Questions

What is the current Silo Pharma, Inc. (SILO) stock price?

Silo Pharma, Inc.(PNK:SILO) stock price is $1.61 in the last trading session. During the trading session, SILO stock reached the peak price of $3.05 while $1.216 was the lowest point it dropped to. The percentage change in SILO stock occurred in the recent session was 1.26% while the dollar amount for the price change in SILO stock was $0.02.

SILO's industry and sector of operation?

The PNK listed SILO is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of SILO?

Mr. Eric Weisblum | Chairman, President & Chief Executive Officer
Dr. James S. Kuo M.B.A., M.D. | Vice President of Research & Development
Mr. Daniel E. Ryweck | Chief Financial Officer

How many employees does SILO have?

Number of SILO employees currently stands at 3. SILO operates from 560 Sylvan Avenue, Englewood Cliffs, NJ 07632, US.

Link for SILO official website?

Official Website of SILO is:

How do I contact SILO?

SILO could be contacted at phone #718 400 9031 and can also be accessed through its website. SILO operates from 560 Sylvan Avenue, Englewood Cliffs, NJ 07632, US.

How many shares of SILO are traded daily?

The average number of SILO shares traded daily for last 3 months was 114.26K.

What is the market cap of SILO currently?

The market value of SILO currently stands at $4.21M with its latest stock price at $1.61